基本信息
浏览量:73
职业迁徙
个人简介
Dr. Kaushansky has been continuously funded by the National Institutes of Health to perform cutting edge biomedical research for 30 years. The goal of the Kaushansky laboratory is to understand, and manipulate for therapeutic benefit, blood cell production. Towards this end, his team has cloned several of the genes important in the growth and differentiation of blood cells, including thrombopoietin, a key regulator of stem cell and platelet production. This work ultimately lead to others developing two drugs currently approved by the FDA to treat low blood platelet counts, and has resulting in his penning well over 200 scholarly publications.
研究兴趣
论文共 164 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Stem cells (Dayton, Ohio)no. Supplement 1 (2021): 2548-2548
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn